Follow
Jordi Minguillón
Jordi Minguillón
Postdoctoral Researcher
Verified email at salud.madrid.org
Title
Cited by
Cited by
Year
Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia
M Bogliolo, B Schuster, C Stoepker, B Derkunt, Y Su, A Raams, JP Trujillo, ...
The American Journal of Human Genetics 92 (5), 800-806, 2013
3762013
Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5
M Buxadé, G Lunazzi, J Minguillón, S Iborra, R Berga-Bolaños, M Del Val, ...
Journal of Experimental Medicine 209 (2), 379-393, 2012
1732012
Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5
J Aramburu, K Drews-Elger, A Estrada-Gelonch, J Minguillón, ...
Biochemical pharmacology 72 (11), 1597-1604, 2006
1652006
Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-β1 biosynthesis, whereas higher doses of cyclosporin A trigger …
J Minguillon, B Morancho, SJ Kim, M Lopez-Botet, J Aramburu
Journal of leukocyte biology 77 (5), 748-758, 2005
552005
Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice
B Morancho, J Minguillón, JD Molkentin, C López-Rodríguez, J Aramburu
BMC molecular biology 9, 1-13, 2008
532008
Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1
G Hernández, MJ Ramírez, J Minguillón, P Quiles, G Ruiz de Garibay, ...
Nature communications 9 (1), 967, 2018
412018
Gefitinib and afatinib show potential efficacy for Fanconi anemia–related head and neck cancer
H Montanuy, Á Martínez-Barriocanal, J Antonio Casado, L Rovirosa, ...
Clinical Cancer Research 26 (12), 3044-3057, 2020
252020
Chromosome fragility in the buccal epithelium in patients with Fanconi anemia
MJ Ramírez, J Minguillón, S Loveless, K Lake, E Carrasco, N Stjepanovic, ...
Cancer Letters 472, 1-7, 2020
182020
Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients
MJ Ramírez, R Pujol, JP Trujillo‐Quintero, J Minguillón, M Bogliolo, P Río, ...
American Journal of Hematology 96 (8), 989-999, 2021
142021
CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
J Luque, I Mendes, B Gómez, B Morte, M López de Heredia, E Herreras, ...
Clinical Genetics 101 (5-6), 481-493, 2022
92022
Epigenetic alterations in Fanconi anaemia: role in pathophysiology and therapeutic potential
H Belo, G Silva, BA Cardoso, B Porto, J Minguillon, J Barbot, J Coutinho, ...
PloS one 10 (10), e0139740, 2015
82015
Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia
R Errazquin, A Page, A Suñol, C Segrelles, E Carrasco, J Peral, ...
Oral Oncology 134, 106184, 2022
62022
High content drug screening for Fanconi anemia therapeutics
H Montanuy, C Camps-Fajol, J Carreras-Puigvert, M Häggblad, ...
Orphanet Journal of Rare Diseases 15, 1-9, 2020
62020
Therapeutic research in the crystal chromosome disease Fanconi anemia
J Minguillón, J Surralles
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 836, 104-108, 2018
52018
Fanconi-like anemia related to a FANCM mutation
JA Encarnación, P Cerezuela, I Español, MR García, C Manso, ...
European Journal of Medical Genetics 65 (1), 104399, 2022
42022
Donor selection for adoptive cell therapy with CD45RA− memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype …
K Al-Akioui-Sanz, B Pascual-Miguel, M Díaz-Almirón, C Mestre-Durán, ...
Cytotherapy 25 (3), 330-340, 2023
32023
Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia
JA Casado, A Valeri, R Sanchez-Domínguez, P Vela, A López, S Navarro, ...
The Journal of Clinical Investigation 132 (15), 2022
32022
Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients
P Riera, B Rodríguez-Santiago, A Lasa, L Gonzalez-Quereda, B Martín, ...
Cancers 12 (8), 2245, 2020
22020
TURNING NKG2D CAR-T THERAPY INTO AN IMPROVED IL18 TRUCK AS A TREATMENT FOR PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
L Clares-Villa, L Pertinez, A Navarro-Zapata, C Mestre-Duran, ...
HUMAN GENE THERAPY 34 (21-22), A16-A16, 2023
2023
OPTIMIZING MULTITARGET APPROACH IN THE PEDIATRIC PATIENT: NEW PERSPECTIVES OF DUAL CD19/CD22 CAR-T
V Galan-Gomez, B Gonzalez Martinez, I Mirones Aguilar, ...
BONE MARROW TRANSPLANTATION 58 (SUPP 1), 198-199, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20